ES8106834A1 - Antibody serum - Google Patents

Antibody serum

Info

Publication number
ES8106834A1
ES8106834A1 ES495177A ES495177A ES8106834A1 ES 8106834 A1 ES8106834 A1 ES 8106834A1 ES 495177 A ES495177 A ES 495177A ES 495177 A ES495177 A ES 495177A ES 8106834 A1 ES8106834 A1 ES 8106834A1
Authority
ES
Spain
Prior art keywords
igg
agglutination
serum
cells
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES495177A
Other languages
Spanish (es)
Other versions
ES495177A0 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gamma Biologicals Inc
Original Assignee
Gamma Biologicals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gamma Biologicals Inc filed Critical Gamma Biologicals Inc
Publication of ES8106834A1 publication Critical patent/ES8106834A1/en
Publication of ES495177A0 publication Critical patent/ES495177A0/en
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/34—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Blood grouping serum containing antibodies specific to human blood antigens and capable of direct agglutination of red blood cells without enhancing the spontaneous agglutination of immunoglobulin- coated cells, are produced by treating whole serum or a fraction containing IgG antibodies, separating IgM and IgG, reducing and thereby breaking disulfide bonds in the IgG, fixing the reduced IgG to prevent re-oxidation, and recombining with IgG.
ES495177A 1979-12-26 1980-09-19 A METHOD OF PRODUCING AN ANTI-SERUM THAT HAS A BETTER BINDING QUALITY Granted ES495177A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10749979A 1979-12-26 1979-12-26

Publications (2)

Publication Number Publication Date
ES8106834A1 true ES8106834A1 (en) 1981-09-01
ES495177A0 ES495177A0 (en) 1981-09-01

Family

ID=22316939

Family Applications (1)

Application Number Title Priority Date Filing Date
ES495177A Granted ES495177A0 (en) 1979-12-26 1980-09-19 A METHOD OF PRODUCING AN ANTI-SERUM THAT HAS A BETTER BINDING QUALITY

Country Status (7)

Country Link
JP (1) JPS5694267A (en)
AU (1) AU6071780A (en)
DE (1) DE3028977A1 (en)
ES (1) ES495177A0 (en)
GB (1) GB2066259B (en)
IT (1) IT8049473A0 (en)
NZ (1) NZ194363A (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61213673A (en) * 1985-03-19 1986-09-22 Morinaga Milk Ind Co Ltd Production of reagent for immunological measurement
CA2008213A1 (en) * 1989-02-21 1990-08-21 David A. Hilborn Method of fragmenting certain monoclonal antibodies
GB8919761D0 (en) * 1989-09-01 1989-10-18 Central Blood Lab Authority Chemical compounds
EP1465720A4 (en) * 2001-12-19 2010-05-12 Biogen Idec Inc Methods for detecting half-antibodies using chip-based gel electrophoresis
US20070275481A1 (en) * 2003-11-24 2007-11-29 Biogen Idec Ma Inc. Methods For Detecting Half-Antibodies Using Chip Based Gel Electophoresis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5417721B2 (en) * 1974-03-08 1979-07-02
ZA804197B (en) * 1979-07-13 1982-02-24 Ortho Diagnostics Anti-d test and reagent

Also Published As

Publication number Publication date
GB2066259B (en) 1983-05-25
JPS5694267A (en) 1981-07-30
NZ194363A (en) 1982-12-21
IT8049473A0 (en) 1980-08-12
AU6071780A (en) 1981-07-02
GB2066259A (en) 1981-07-08
DE3028977A1 (en) 1981-07-02
ES495177A0 (en) 1981-09-01

Similar Documents

Publication Publication Date Title
FI800140A (en) FOERFARANDE FOER DETEKTERING AV HEMOGLOBIN I AVFOERING
SE8105827L (en) IMMUNO ANALYSIS PRODUCTS AND METHODS
IL76142A0 (en) Monoclonal antibody specific to human carcinoma tumorassociated antigen,hybrid cell lines producing the same and methods for the use thereof
NZ192959A (en) Method and microspheres for magnetic separation of cells bacteria or viruses
AU7307881A (en) Determination of antigens with monoclonal antibodies
DE3584035D1 (en) DETECTION OF HUMAN CYTOMEGALOVIRUS-SPECIFIC IGM.
ZA887771B (en) Monoclonal antibody specific to a novel epitope of the lfa-1 antigen of human t lymphocytes
OA08485A (en) Monoclonal antibodies and antigen for human non-small cell lung carcinoma and certain other human carcinomas.
GB2191577B (en) Layered immunoassay using antibodies bound to transport particles to determine the presence of an antigen
ES520012A0 (en) AGGLUTINATION PROCEDURE WITH LATEX FOR THE DETECTION OR DETERMINATION OF A PARTICIPANT IN AN IMMUNOLOGICAL REACTION.
ES8505406A1 (en) Anti-human cytomegalovirus-monoclonal antibodies, hybridomas secreting those antibodies and polypeptides carrying a sequential antigenic determinant of human cytomegalovirus.
EP0131627A4 (en) Specific cea-family antigens, antibodies specific thereto and their methods of use.
ES8106834A1 (en) Antibody serum
IL61641A0 (en) Immunological detection of human cancer cells and antigens and antibodies for use therein
ES8602253A1 (en) Monoclonal immunoglobulin M antibodies and method of preparation.
AU2911289A (en) Carcinoma-associated antigens, and antibodies which recognize these antigens
EP0248147A3 (en) Method of determining the presence of cancer cells
AU582129B2 (en) Circulating antigens of dirofilaria immitis,monoclonal antibodies specific therefor and methods of preparing such antibodies and detecting such antigens
SASAHIRA SERODIAGNOSIS OF SYPHILIS BY FLUORESCENT TREPONEMAL ANTIBODY TEST (FTA TEST). 2. ON THE TRANSITION OF ANTIBODIES OF 7 S GAMMA TYPE IN THE SYPHILITIC SERA IN EACH STAGE AND THE SPECIFICITY OF FTA TEST
SU1356287A1 (en) METHOD OF OBTAINING IMMUNE SERIES
HRP940830B1 (en) Hybrid cell line for producing monoclonal antibody to a human t cell antigen, antibody, and methods
PL245361A1 (en) Method of obtaining antibodies specific for antigens isolated from human serum,in particular for the antigen hbs.
ES8608321A1 (en) Monoclonal antibody specific for human immunoglobulin
IL67944A0 (en) Antibodies and antigens useful in the diagnosis and treatment of cancer,methods for the production thereof and methods for testing for the presence of cancer cells using the same
ATE76510T1 (en) SPECIFIC ANTIGENS OF THE CEA (CARZYNO-EMBRYAL ANTIGEN) FAMILY, SPECIFIC ANTIBODIES AND METHODS OF USE.